EBC 46 Human Trials: Promising Results in Cancer Treatment
EBC 46, a novel therapeutic agent derived from the Australian plant Blushwood (Hylandia dockrillii), has garnered significant attention in the field of oncology due to its unique mechanism of action and promising efficacy against various types of tumors. This compound is particularly notable for its ability to induce localized tumor necrosis, effectively targeting cancer cells […]
EBC 46 Human Trials: Promising Results in Cancer Treatment Read More »










